124 related articles for article (PubMed ID: 1349764)
1. [Imidazopyridines, an alternative to benzodiazepines].
Dessibourg CA
Schweiz Rundsch Med Prax; 1992 Apr; 81(17):555-6. PubMed ID: 1349764
[TBL] [Abstract][Full Text] [Related]
2. Reduction of reticulata neuronal activity by zolpidem and alpidem, two imidazopyridines with high affinity for type I benzodiazepine receptors.
Mereu G; Carcangiu G; Concas A; Passino N; Biggio G
Eur J Pharmacol; 1990 Apr; 179(3):339-45. PubMed ID: 1973107
[TBL] [Abstract][Full Text] [Related]
3. Tolerance to a new class of non-benzodiazepine anxiolytics.
Chodera A; Nowakowska E; Bartczak G
Pol J Pharmacol; 1994; 46(5):479-81. PubMed ID: 7894538
[TBL] [Abstract][Full Text] [Related]
4. [Contribution of zolpidem in the management of sleep disorders].
Lavoisy J; Zivkovic B; Benavides J; Perrault GH; Robert P
Encephale; 1992; 18(4):379-92. PubMed ID: 1363657
[TBL] [Abstract][Full Text] [Related]
5. Zolpidem and alpidem: two imidazopyridines with selectivity for omega 1- and omega 3-receptor subtypes.
Langer SZ; Arbilla S; Benavides J; Scatton B
Adv Biochem Psychopharmacol; 1990; 46():61-72. PubMed ID: 1981304
[No Abstract] [Full Text] [Related]
6. Imidazopyridines: towards novel hypnotic and anxiolytic drugs.
George P; Rossey G; Depoortere H; Mompon B; Allen J; Wick A
Farmaco; 1991 Jan; 46(1 Suppl):277-88. PubMed ID: 1677245
[No Abstract] [Full Text] [Related]
7. Trends in anxiolytic-hypnotic use and polypharmacy in Taiwan, 2002-2009: a nationwide, population-based survey.
Wang LJ; Chen YC; Chen CK; Chou WJ; Chou MC
Psychiatr Serv; 2014 Feb; 65(2):208-14. PubMed ID: 24233182
[TBL] [Abstract][Full Text] [Related]
8. Zolpidem, a valuable alternative to benzodiazepine hypnotics for chronic insomnia?
Declerck A; Smits M
J Int Med Res; 1999; 27(6):253-63. PubMed ID: 10726234
[TBL] [Abstract][Full Text] [Related]
9. Alpidem from pharmacology to clinic.
Garreau M; Zivkovic B; Morselli PL
Clin Neuropharmacol; 1992; 15 Suppl 1 Pt A():407A-408A. PubMed ID: 1354046
[No Abstract] [Full Text] [Related]
10. Pilot study of alpidem, a new nonbenzodiazepine anxiolytic, in the treatment of generalized anxiety disorder.
Schweizer E; Csanalosi I; Rickels K
J Clin Psychopharmacol; 1988 Feb; 8(1):74. PubMed ID: 2895127
[No Abstract] [Full Text] [Related]
11. [Double-blind versus placebo comparison of single dose alpidem (50 mg or 75 mg) in a model of situational anxiety].
Regnier F; Chastel A; L'Heritier C; Magni G; Henry M
Therapie; 1989; 44(4):279-83. PubMed ID: 2574502
[TBL] [Abstract][Full Text] [Related]
12. [New non-benzodiazepine hypnotics. Progress in therapy of sleep disorders?].
Hajak G; Rüther E
Internist (Berl); 1995 Nov; 36(11):1085-90; discussion 1090-1. PubMed ID: 8543446
[No Abstract] [Full Text] [Related]
13. [Abrupt shift to zolpidem, a new imidazopyridine hypnotic, in insomniac patients previously treated with benzodiazepine hypnotics].
Ciapparelli A; Colombo C; Cuccato G; Levi-Minzi A; Lorizio A; Maggioni M; Siciliano G; Silvestri R; Biondi F; Casadei GL
Minerva Psichiatr; 1993 Mar; 34(1):29-38. PubMed ID: 8098502
[TBL] [Abstract][Full Text] [Related]
14. Studies with alpidem in normal volunteers and anxious patients.
Morton S; Lader M
Pharmacopsychiatry; 1990 May; 23 Suppl 3():120-3. PubMed ID: 1974071
[TBL] [Abstract][Full Text] [Related]
15. A comparison of alpidem and placebo in relieving benzodiazepine withdrawal symptoms.
Lader M; Farr I; Morton S
Int Clin Psychopharmacol; 1993; 8(1):31-6. PubMed ID: 8097214
[TBL] [Abstract][Full Text] [Related]
16. Simultaneous screening and quantitation of alpidem, zolpidem, buspirone and benzodiazepines by dual-channel gas chromatography using electron-capture and nitrogen-phosphorus detection after solid-phase extraction.
Gaillard Y; Gay-Montchamp JP; Ollagnier M
J Chromatogr; 1993 Dec; 622(2):197-208. PubMed ID: 7908670
[TBL] [Abstract][Full Text] [Related]
17. Clinical studies with the new anxiolytic alpidem in anxious patients: an overview of the European experiences.
Musch B; Morselli PL; Priore P
Pharmacol Biochem Behav; 1988 Apr; 29(4):803-6. PubMed ID: 2901120
[TBL] [Abstract][Full Text] [Related]
18. Pilot study of alpidem, a novel imidazopyridine compound, in anxiety.
Langer SF; Feighner Jp; Pambakian R; Manowitz NR; Venable TC
Psychopharmacol Bull; 1988; 24(1):161-3. PubMed ID: 2898793
[No Abstract] [Full Text] [Related]
19. A comparative study of alpidem, a nonbenzodiazepine, and lorazepam in patients with nonpsychotic anxiety.
Diamond BI; Nguyen H; O'Neal E; Ochs R; Kaffeman M; Borison RL
Psychopharmacol Bull; 1991; 27(1):67-71. PubMed ID: 1677774
[TBL] [Abstract][Full Text] [Related]
20. Alpidem and lorazepam in the treatment of patients with anxiety disorders: comparison of physiological and psychological effects.
Morton S; Lader M
Pharmacopsychiatry; 1992 Jul; 25(4):177-81. PubMed ID: 1356277
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
